Insider trades

Ron Bentsur, Chairman of Nuvectis Pharma NVCT, has filed 33 purchases and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $28.6K. The latest trade was on 01/06.

Ron Bentsur

Chairman & CEO
First filing
23/01/13
Trades
49 trades
Buys / sales
33 / 0
12-month net buying
$28.6K
Last trade
01/06

Trading activity

Transactions

Trade type
Open-market buy25/11/0525/11/065,000 sh$5.72$28,600+0.1%
Open-market buy24/12/2424/12/264,500 sh$4.65$20,925+0.1%
Open-market buy24/11/1524/11/1820,000 sh$4.92$98,400+0.6%
Open-market buy24/05/1424/05/151,940 sh$6.74$13,075.6+0.1%
Open-market buy24/05/1024/05/132,000 sh$6.40$12,800+0.1%
Open-market buy24/03/1824/03/195,000 sh$10.29$51,450+0.2%
Open-market buy23/10/1023/10/12640 sh$11.08$7,091.2+0.0%
NVCT
Open-market buy23/10/06–23/10/0923/10/101,080 sh2 trades$11.21avg.$12,105.2+0.0%
NVCT
Open-market buy23/10/04–23/10/0523/10/063,220 sh2 trades$11.01avg.$35,455+0.1%
NVCT
Open-market buy23/08/15–23/08/1623/08/16350 sh2 trades$14.61avg.$5,112.15+0.0%
NVCT
Open-market buy23/08/08–23/08/1123/08/11300 sh2 trades$14.73avg.$4,418.4+0.0%
NVCT
Open-market buy23/07/20–23/07/2123/07/24335 sh2 trades$14.92avg.$4,997.85+0.0%
Open-market buy23/07/1923/07/20200 sh$14.33$2,866+0.0%
NVCT
Open-market buy23/07/07–23/07/1423/07/18260 sh2 trades$15.52avg.$4,035.4+0.0%
Open-market buy23/07/0623/07/07320 sh$14.88$4,761.6+0.0%
Open-market buy23/06/2623/06/27750 sh$16.50$12,375+0.0%
Open-market buy23/06/2123/06/22500 sh$17.88$8,940+0.0%
NVCT
Open-market buy23/06/07–23/06/0823/06/08350 sh2 trades$17.45avg.$6,107.9+0.0%
Open-market buy23/05/3123/06/01330 sh$17.28$5,702.4+0.0%
Open-market buy23/05/2423/05/26200 sh$17.49$3,498+0.0%